Without clear timelines and accountability, Ireland risks falling short of its goal to end new HIV transmissions by 2030.

Lots of scholarship assumes that partners in higher-quality relationships work together to reduce health-related risks. A new study tested this assumption.

Indian generic manufacturers will produce lenacapavir, a near 100% effective, six-month injectable HIV prevention drug, ...

GENEVA/NEW YORK, 27 September 2025 —UNAIDS has wrapped up UNGA80 week with a productive mix of high-level events, announcements and decisions. The week kicked off with a face-to-face meeting of the ...

A game-changer in HIV prevention. moses sagwe26 September 2025 - 14:54 ...

New partnership will join others to expand access to generic lenacapavir for millions more people at risk of HIV in high-burden countries—bringing the world closer to ending the epidemic - Kenya ...

A partnership will enable low-cost, generic lenacapavir for HIV prevention in LMICs, aiming to improve access and reduce infections significantly.

A twice-yearly injection described as the most promising HIV prevention tool in decades is poised to reach millions more people, with new generic versions priced at about $40 per patient per year.

Millions more people at risk of HIV in low- and middle-income countries (LMICs) will have access to a powerful new prevention option: a low-cost, generic ...

The twice-yearly drug has been hailed as a medical breakthrough that could change the course of the HIV epidemic.View on ...